New Onset Alacrima as a Presenting Feature of a Skull Base Chondrosarcoma.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
Historique:
pubmed:
20
5
2020
medline:
19
3
2021
entrez:
20
5
2020
Statut:
ppublish
Résumé
Acquired unilateral alacrima as a presenting sign of an intracranial tumor is exceptionally rare, and only described once previously in a case of nasopharyngeal carcinoma. The authors present a 32-year-old female patient who presents with a year-long history of alacrima and arhinorrhea. She was subsequently diagnosed with a petroclival chondrosarcoma extending into Meckel's cave and the cavernous sinus and underwent surgical debulking. To the authors' knowledge, this is the first reported case of acquired unilateral alacrima as a presenting feature of a skull base chondrosarcoma. This case serves to remind general ophthalmologists and oculoplastic surgeons alike that acquired alacrima may be the presenting feature of serious intracranial disease.
Identifiants
pubmed: 32427732
doi: 10.1097/IOP.0000000000001683
pii: 00002341-202011000-00035
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e154-e156Références
Sjogren H, Eriksen A. Alacrimia congenita. Br J Ophthalmol. 1950; 34:691–694
Duarte AF, Akaishi PM, de Molfetta GA, et al. Lacrimal gland involvement in blepharophimosis-ptosis-epicanthus inversus syndrome. Ophthalmology. 2017; 124:399–406
Allgrove J, Clayden GS, Grant DB, et al. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet. 1978; 1:1284–1286
Ko AC, Satterfield KR, Lee BW, et al. Unilateral alacrima as a presenting symptom of nasopharyngeal carcinoma. Ophthalmic Plast Reconstr Surg. 2017; 33:e41–e42
Rosenberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999; 23:1370–1378
Richardson MS. Pathology of skull base tumors. Otolaryngol Clin North Am. 2001; 34:1025–1042
Awad M, Gogos AJ, Kaye AH. Skull base chondrosarcoma. J Clin Neurosci. 2016; 24:1–5
Bloch OG, Jian BJ, Yang I, et al. Cranial chondrosarcoma and recurrence. Skull Base. 2010; 20:149–156
Campbell RG, Prevedello DM, Ditzel Filho L, et al. Contemporary management of clival chordomas. Curr Opin Otolaryngol Head Neck Surg. 2015; 23:153–161
Cho HY, Lee M, Takei H, et al. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma. Appl Immunohistochem Mol Morphol. 2009; 17:131–138
Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol. 2008; 21:1461–1469